Life Science News

Latest updates from the biotech and pharma world

BioWorld 2025-12-10

Prelude Therapeutics divulges new JAK2 inhibitors

BioWorld 2025-12-10

Amgen describes new GTPase KRAS mutant inhibitors

BioWorld 2025-12-10

New CDK2 and CDK4 degradation inducers disclosed in Nikang Therapeutics patent

BioWorld 2025-12-10

Immuse Therapeutics discovers new LRRK2 inhibitors

BioWorld 2025-12-09

Pfizer adds heft to obesity pipeline in $2B Yaopharma deal

BioWorld 2025-12-09

Crescent, Kelun in two-way deal, including PD-1/VEGF bispecific

BioWorld 2025-12-09

Aimedbio debuts with $48M Kosdaq IPO

BioWorld 2025-12-09

Kazia raises AU$50M to advance PI3K/mTOR inhibitor paxalisib

BioWorld 2025-12-09

14 psoriasis therapies projected to launch in China by 2027

BioWorld 2025-12-09

ASH 2025: Tec-dara shines on ‘functional cure’ Majestec-3 MM data

BioWorld 2025-12-09

GSK goes away, Ideaya synthetic lethality bids in-house again

BioWorld 2025-12-09

New antibody-drug conjugates disclosed in Genome & Co. patent

BioWorld 2025-12-09

Merck Sharp & Dohme discovers new GTPase KRAS degradation inducers

BioWorld 2025-12-08

Other news to note for Dec. 8, 2025

BioWorld 2025-12-08

Regulatory actions for Dec. 8, 2025

BioWorld 2025-12-08

Viatris monetizes equity stake in Biocon, gets $400M cash

BioWorld 2025-12-08

GSK goes away, Ideaya synthetic lethality bids in-house again

BioWorld 2025-12-08

Mirum adds to rare live disease portfolio with $820M Bluejay buy

BioWorld 2025-12-08

ASH 2025: Speeding AML research with MRD surrogate endpoint

BioWorld 2025-12-08

Med-tech gainers and losers for Dec. 1-5, 2025

14 / 20